Skip to content
The GLP-1 Verdict
Menu

The alternatives

The best alternatives to Renlo Health

Renlo Health scores 85/100 (grade B, ranked #28) on The Verdict Score. Here are the GLP-1 providers we'd weigh against it, scored on the same six-factor rubric. Partners we work with carry a small, fixed edge in where they are listed; the scores themselves are not adjusted.

This shortlist uses nearby positions in our published ranking, with our featured partner shown first. It compares program terms and features; your clinician must assess treatment suitability.

Published by The GLP-1 Verdict

Pricing sources checked: latest October 2026

Check dates vary by provider.

  • Renlo Health: September 2026
  • CoreAge Rx: August 2026
  • No BS RX: September 2026
  • Direct Meds: October 2026
  • Telos Rx: Check date not recorded
  • Alan Meds: August 2026
  • Hims & Hers: October 2026
  • Henry Meds: October 2026

Read our full Renlo Health review →

Grade B

No BS RX

Six programs across four terms on one public page, four dispensing pharmacies named with addresses, and a no-intro-rate commitment the arithmetic actually supports.

No BS RX matches Renlo Health at 85/100; our full write-up on No BS RX has the pricing conditions and the caveats in detail.

Sema
$179/mo (compounded; a low-dose program is $140)
Tirz
$249/mo (compounded; a low-dose program is $140)
Coverage
Not publicly listed
Grade B−

Direct Meds

One of the rare programs offering a sublingual route on both molecules with all-inclusive pricing and a nurse team to call — but a 90-day supply ships at once, and its prices have climbed well above what it once advertised.

Direct Meds scores 82/100 to Renlo Health's 85; our Direct Meds review in full has the pricing conditions and the caveats in detail.

Sema
From $249/mo sublingual, $297/mo injectable (90-day supply, billed monthly)
Tirz
From $299/mo sublingual, $399/mo injectable (90-day supply, billed monthly)
Coverage
48 states (not Mississippi or Louisiana)
Grade B

Telos Rx

Carries one of the deepest published catalogs in the ranking — compounded semaglutide and tirzepatide plus needle-free oral and microdosed routes, PT-141, intranasal NAD+ and a wall of recovery peptides — and backs it with a checkable LegitScript certification and HIPAA compliance, but the verdict docks it hard because every line is compounded, not FDA-approved, and the pricing turns opaque the moment you look past the headline GLP-1 tiers.

Telos Rx matches Renlo Health at 85/100; our Telos Rx review in full has the pricing conditions and the caveats in detail.

Sema
$49/mo (microdosed, annual)
Tirz
$99/mo (annual)
Coverage
Not publicly listed
Grade B

Alan Meds

Rock-bottom pricing on both molecules plus an oral route, nationwide — with the trade-off of no LegitScript listing.

Alan Meds scores 84/100 to Renlo Health's 85; our Alan Meds review in full has the pricing conditions and the caveats in detail.

Sema
$99/mo
Tirz
$325/mo
Coverage
All 50 states
Grade B

Hims & Hers

Mass-market, app-first weight program now selling only brand-name GLP-1s — Wegovy, Zepbound, Ozempic and the Foundayo pill — with consumer-grade polish.

Hims & Hers matches Renlo Health at 85/100; our full write-up on Hims & Hers has the pricing conditions and the caveats in detail.

Sema
From $149/mo (brand Wegovy pill)
Tirz
From $299/mo (brand Zepbound)
Coverage
Most states (not all 50)
Grade B

Henry Meds

A flat-fee compounded pioneer — simple model, but priced at the higher end now.

Henry Meds scores 84/100 to Renlo Health's 85; our full write-up on Henry Meds has the pricing conditions and the caveats in detail.

Sema
$297/mo (compounded injection)
Tirz
$349/mo (oral tablets, 3-month plan)
Coverage
Multi-state

See the complete rankings, the alternatives to every provider, A to Z, or head to the comparison hub.

Pricing, states and verification reflect each provider's public disclosures at last review; the Verdict Score is our editorial judgment per the methodology. Not medical advice; see our disclosure.